118 related articles for article (PubMed ID: 8143238)
21. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein.
Charleson S; Evans JF; Léger S; Perrier H; Prasit P; Wang Z; Vickers PJ
Eur J Pharmacol; 1994 May; 267(3):275-80. PubMed ID: 8088366
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator-activated receptor alpha activator, Wy14,643, is anti-inflammatory in vivo.
Colville-Nash P; Willis D; Papworth J; Freemantle C; Lam C; Andrews G; Willoughby D
Inflammopharmacology; 2005; 12(5-6):493-504. PubMed ID: 16259717
[TBL] [Abstract][Full Text] [Related]
24. The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
Kusner EJ; Buckner CK; Dea DM; DeHaas CJ; Marks RL; Krell RD
Eur J Pharmacol; 1994 May; 257(3):285-92. PubMed ID: 7522174
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis.
Peres CM; de Paula L; Medeiros AI; Sorgi CA; Soares EG; Carlos D; Peters-Golden M; Silva CL; Faccioli LH
Microbes Infect; 2007 Apr; 9(4):483-9. PubMed ID: 17347013
[TBL] [Abstract][Full Text] [Related]
26. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
27. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells.
Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C
Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079
[TBL] [Abstract][Full Text] [Related]
28. Blockade of leukotriene B4 prevents articular incapacitation in rat zymosan-induced arthritis.
da Rocha FA; Teixeira MM; Rocha JC; Girão VC; Bezerra MM; Ribeiro Rde A; Cunha Fde Q
Eur J Pharmacol; 2004 Aug; 497(1):81-6. PubMed ID: 15321738
[TBL] [Abstract][Full Text] [Related]
29. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
Surette ME; Krump E; Picard S; Borgeat P
Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
[TBL] [Abstract][Full Text] [Related]
30. Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase.
Hutchinson JH; Charleson S; Evans JF; Falgueyret JP; Hoogsteen K; Jones TR; Kargman S; Macdonald D; McFarlane CS; Nicholson DW
J Med Chem; 1995 Oct; 38(22):4538-47. PubMed ID: 7473582
[TBL] [Abstract][Full Text] [Related]
31. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.
Depré M; Van Hecken A; Verbesselt R; De Lepeleire I; Schwartz J; Porras A; Larson P; Lin C; De Schepper PJ
Int J Clin Pharmacol Res; 1998; 18(2):53-61. PubMed ID: 9675622
[TBL] [Abstract][Full Text] [Related]
33. Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the archidonic acid-induced mouse ear inflammation test.
Burchardt ER; Müller-Peddinghaus R
Prostaglandins Leukot Essent Fatty Acids; 1997 Apr; 56(4):301-6. PubMed ID: 9150376
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells.
Vondrácek J; Stika J; Soucek K; Minksová K; Bláha L; Hofmanová J; Kozubík A
Eur J Pharmacol; 2001 Jul; 424(1):1-11. PubMed ID: 11470254
[TBL] [Abstract][Full Text] [Related]
35. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
[TBL] [Abstract][Full Text] [Related]
36. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
37. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
Engelhardt G; Bögel R; Schnitzler C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
[TBL] [Abstract][Full Text] [Related]
38. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
[TBL] [Abstract][Full Text] [Related]
39. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
Steinhilber D
Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
[TBL] [Abstract][Full Text] [Related]
40. Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach.
Peskar BM
Gastroenterology; 1991 Mar; 100(3):619-26. PubMed ID: 1993484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
